Search for: "T. G., II" Results 81 - 100 of 2,340
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Apr 2018, 6:16 am by Guido Paola
The statement setting out the grounds of appeal was received on 19 November 2014.II. [read post]
29 May 2017, 11:15 pm by Roel van Woudenberg
Independent claim 15 related to a kit for producing dental materials comprising a base component containing from 0.1 to 15% by weight of the fluidity improver of claim 1.II. [read post]
30 Oct 2017, 5:31 am by Nico Cordes
Scope of the interlocutory decisionThe present decision was taken by the alternate board composition established under Article 24(4) EPC in order to decide on an objection of suspected partiality raised under Article 24(3) EPC (see above points II, VI). [read post]
31 Jul 2017, 8:14 am by Roel van Woudenberg
G 1/03 and G 2/10 relate to different cases, so cannot prima facie be considered as somehow conflicting, but Board 3.3.09 made the currently pending referral G 1/16 while handling appeal T 0437/14 asking a.o. whether the G 2/10 decision effects how some aspects of G 1/03 shall be interpreted. [read post]
28 May 2019, 3:45 am by Jessica Kroeze
The disclaimer was consequently allowable under G 1/16 and G 1/03.Auxiliary request III - Novelty vis-à-vis D1The subject-matter of claim 1 was novel over the disclosure in D1. [read post]
28 Oct 2010, 3:01 pm by Oliver G. Randl
Decisions G 9/91, G 10/91 and T 433/93 were cited in that respect. [read post]
14 Jun 2010, 3:00 pm by Kim Krawiec
Société Générale: Back In The Saddle Again?? [read post]
20 May 2024, 1:34 am by Rose Hughes
Prior to G 3/19, the EBA had found in G 2/12 (Broccoli/Tomato II) that the EPC did not exclude plant and animal products produced by essentially biological processes from patentability. [read post]
27 Feb 2012, 5:01 pm by Oliver G. Randl
T 870/92, T 19/97, T 478/99, T 413/02, T 6/05). [read post]
6 Jan 2011, 3:01 pm by Oliver G. Randl
Thus reimbursement under (ii) is excluded as well. [read post]